Intellia Therapeutics Inc (NTLA)
23.80
+0.51
(+2.19%)
USD |
NASDAQ |
May 03, 11:42
Intellia Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.02K% |
| June 30, 2023 | -909.8% |
| March 31, 2023 | -818.1% |
| December 31, 2022 | -835.5% |
| September 30, 2022 | -853.5% |
| June 30, 2022 | -717.6% |
| March 31, 2022 | -1.31K% |
| December 31, 2021 | -632.0% |
| September 30, 2021 | -994.5% |
| June 30, 2021 | -1.05K% |
| March 31, 2021 | -716.9% |
| December 31, 2020 | -639.8% |
| September 30, 2020 | -125.3% |
| June 30, 2020 | -199.2% |
| March 31, 2020 | -246.3% |
| December 31, 2019 | -258.6% |
| September 30, 2019 | -222.6% |
| June 30, 2019 | -231.0% |
| Date | Value |
|---|---|
| March 31, 2019 | -210.3% |
| December 31, 2018 | -242.0% |
| September 30, 2018 | -306.5% |
| June 30, 2018 | -289.4% |
| March 31, 2018 | -285.9% |
| December 31, 2017 | -359.4% |
| September 30, 2017 | -209.9% |
| June 30, 2017 | -263.5% |
| March 31, 2017 | -203.2% |
| December 31, 2016 | -187.7% |
| September 30, 2016 | -153.7% |
| June 30, 2016 | -164.1% |
| March 31, 2016 | -376.4% |
| December 31, 2015 | -309.8% |
| September 30, 2015 | -178.9% |
| June 30, 2015 | -220.8% |
| March 31, 2015 | -84.99% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.31K%
Minimum
Mar 2022
-125.3%
Maximum
Sep 2020
-654.2%
Average
-717.3%
Median
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 7.71% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| NeuroMetrix Inc | -125.2% |
| Repligen Corp | 1.38% |
| Pacific Biosciences of California Inc | -140.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.82% |
| Return on Assets | -35.35% |
| Return on Invested Capital | -42.82% |
| Return on Net Operating Assets | -288.1% |